Pyrazolo[1,5-a]pyrimidine-based inhibitors of HCV polymerase. 2009

Janeta Popovici-Muller, and Gerald W Shipps, and Kristin E Rosner, and Yongqi Deng, and Tong Wang, and Patrick J Curran, and Meredith A Brown, and M Arshad Siddiqui, and Alan B Cooper, and José Duca, and Michael Cable, and Viyyoor Girijavallabhan
Schering-Plough Research Institute Cambridge, 320 Bent Street, Cambridge, MA 02141, USA. janeta.popovici-muller@spcorp.com

The present paper describes a novel series of HCV RNA polymerase inhibitors based on a pyrazolo[1,5-a]pyrimidine scaffold bearing hydrophobic groups and an acidic functionality. Several compounds were optimized to low nanomolar potencies in a biochemical RdRp assay. SAR trends clearly reveal a stringent preference for a cyclohexyl group as one of the hydrophobes, and improved activities for carboxylic acid derivatives.

UI MeSH Term Description Entries
D008970 Molecular Weight The sum of the weight of all the atoms in a molecule. Molecular Weights,Weight, Molecular,Weights, Molecular
D011720 Pyrazoles Azoles of two nitrogens at the 1,2 positions, next to each other, in contrast with IMIDAZOLES in which they are at the 1,3 positions.
D011743 Pyrimidines A family of 6-membered heterocyclic compounds occurring in nature in a wide variety of forms. They include several nucleic acid constituents (CYTOSINE; THYMINE; and URACIL) and form the basic structure of the barbiturates.
D004353 Drug Evaluation, Preclinical Preclinical testing of drugs in experimental animals or in vitro for their biological and toxic effects and potential clinical applications. Drug Screening,Evaluation Studies, Drug, Pre-Clinical,Drug Evaluation Studies, Preclinical,Drug Evaluations, Preclinical,Evaluation Studies, Drug, Preclinical,Evaluation, Preclinical Drug,Evaluations, Preclinical Drug,Medicinal Plants Testing, Preclinical,Preclinical Drug Evaluation,Preclinical Drug Evaluations,Drug Screenings,Screening, Drug,Screenings, Drug
D004791 Enzyme Inhibitors Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction. Enzyme Inhibitor,Inhibitor, Enzyme,Inhibitors, Enzyme
D006526 Hepatitis C INFLAMMATION of the LIVER in humans caused by HEPATITIS C VIRUS, a single-stranded RNA virus. Its incubation period is 30-90 days. Hepatitis C is transmitted primarily by contaminated blood parenterally and is often associated with transfusion and intravenous drug abuse. However, in a significant number of cases, the source of hepatitis C infection is unknown. Hepatitis, Viral, Non-A, Non-B, Parenterally-Transmitted,Parenterally-Transmitted Non-A, Non-B Hepatitis,PT-NANBH,Parenterally Transmitted Non A, Non B Hepatitis
D012321 DNA-Directed RNA Polymerases Enzymes that catalyze DNA template-directed extension of the 3'-end of an RNA strand one nucleotide at a time. They can initiate a chain de novo. In eukaryotes, three forms of the enzyme have been distinguished on the basis of sensitivity to alpha-amanitin, and the type of RNA synthesized. (From Enzyme Nomenclature, 1992). DNA-Dependent RNA Polymerases,RNA Polymerases,Transcriptases,DNA-Directed RNA Polymerase,RNA Polymerase,Transcriptase,DNA Dependent RNA Polymerases,DNA Directed RNA Polymerase,DNA Directed RNA Polymerases,Polymerase, DNA-Directed RNA,Polymerase, RNA,Polymerases, DNA-Dependent RNA,Polymerases, DNA-Directed RNA,Polymerases, RNA,RNA Polymerase, DNA-Directed,RNA Polymerases, DNA-Dependent,RNA Polymerases, DNA-Directed
D012324 RNA-Dependent RNA Polymerase An enzyme that catalyses RNA-template-directed extension of the 3'- end of an RNA strand by one nucleotide at a time, and can initiate a chain de novo. (Enzyme Nomenclature, 1992, p293) Nucleoside-Triphosphate:RNA Nucleotidyltransferase (RNA-directed),RNA Replicase,RNA-Dependent RNA Replicase,RNA-Directed RNA Polymerase,RNA Dependent RNA Polymerase,RNA Dependent RNA Replicase,RNA Directed RNA Polymerase,RNA Polymerase, RNA-Dependent,RNA Polymerase, RNA-Directed,RNA Replicase, RNA-Dependent,Replicase, RNA,Replicase, RNA-Dependent RNA
D012367 RNA, Viral Ribonucleic acid that makes up the genetic material of viruses. Viral RNA
D016174 Hepacivirus A genus of FLAVIVIRIDAE causing parenterally-transmitted HEPATITIS C which is associated with transfusions and drug abuse. Hepatitis C virus is the type species. Hepatitis C virus,Hepatitis C-Like Viruses,Hepaciviruses,Hepatitis C Like Viruses,Hepatitis C viruses,Hepatitis C-Like Virus

Related Publications

Janeta Popovici-Muller, and Gerald W Shipps, and Kristin E Rosner, and Yongqi Deng, and Tong Wang, and Patrick J Curran, and Meredith A Brown, and M Arshad Siddiqui, and Alan B Cooper, and José Duca, and Michael Cable, and Viyyoor Girijavallabhan
November 2013, Bioorganic & medicinal chemistry letters,
Janeta Popovici-Muller, and Gerald W Shipps, and Kristin E Rosner, and Yongqi Deng, and Tong Wang, and Patrick J Curran, and Meredith A Brown, and M Arshad Siddiqui, and Alan B Cooper, and José Duca, and Michael Cable, and Viyyoor Girijavallabhan
January 2021, Bioorganic & medicinal chemistry letters,
Janeta Popovici-Muller, and Gerald W Shipps, and Kristin E Rosner, and Yongqi Deng, and Tong Wang, and Patrick J Curran, and Meredith A Brown, and M Arshad Siddiqui, and Alan B Cooper, and José Duca, and Michael Cable, and Viyyoor Girijavallabhan
January 2011, Bioorganic & medicinal chemistry letters,
Janeta Popovici-Muller, and Gerald W Shipps, and Kristin E Rosner, and Yongqi Deng, and Tong Wang, and Patrick J Curran, and Meredith A Brown, and M Arshad Siddiqui, and Alan B Cooper, and José Duca, and Michael Cable, and Viyyoor Girijavallabhan
January 2011, Bioorganic & medicinal chemistry letters,
Janeta Popovici-Muller, and Gerald W Shipps, and Kristin E Rosner, and Yongqi Deng, and Tong Wang, and Patrick J Curran, and Meredith A Brown, and M Arshad Siddiqui, and Alan B Cooper, and José Duca, and Michael Cable, and Viyyoor Girijavallabhan
May 2009, Bioorganic & medicinal chemistry letters,
Janeta Popovici-Muller, and Gerald W Shipps, and Kristin E Rosner, and Yongqi Deng, and Tong Wang, and Patrick J Curran, and Meredith A Brown, and M Arshad Siddiqui, and Alan B Cooper, and José Duca, and Michael Cable, and Viyyoor Girijavallabhan
January 1978, Il Farmaco; edizione scientifica,
Janeta Popovici-Muller, and Gerald W Shipps, and Kristin E Rosner, and Yongqi Deng, and Tong Wang, and Patrick J Curran, and Meredith A Brown, and M Arshad Siddiqui, and Alan B Cooper, and José Duca, and Michael Cable, and Viyyoor Girijavallabhan
November 2018, Cell chemical biology,
Janeta Popovici-Muller, and Gerald W Shipps, and Kristin E Rosner, and Yongqi Deng, and Tong Wang, and Patrick J Curran, and Meredith A Brown, and M Arshad Siddiqui, and Alan B Cooper, and José Duca, and Michael Cable, and Viyyoor Girijavallabhan
September 2016, Expert opinion on therapeutic patents,
Janeta Popovici-Muller, and Gerald W Shipps, and Kristin E Rosner, and Yongqi Deng, and Tong Wang, and Patrick J Curran, and Meredith A Brown, and M Arshad Siddiqui, and Alan B Cooper, and José Duca, and Michael Cable, and Viyyoor Girijavallabhan
May 2009, Bioorganic & medicinal chemistry letters,
Janeta Popovici-Muller, and Gerald W Shipps, and Kristin E Rosner, and Yongqi Deng, and Tong Wang, and Patrick J Curran, and Meredith A Brown, and M Arshad Siddiqui, and Alan B Cooper, and José Duca, and Michael Cable, and Viyyoor Girijavallabhan
August 1998, Bioorganic & medicinal chemistry letters,
Copied contents to your clipboard!